[The use of corticosteroids in bronchopulmonary dysplasia]
- PMID: 2052111
[The use of corticosteroids in bronchopulmonary dysplasia]
Abstract
In order to study the effect of dexamethasone on the ventilatory function of 13 neonates with bronchopulmonary dysplasia, a retrospective investigation was carried out in the University Hospital Rotterdam, Sophia Children's Hospital, Neonatal Intensive Care Unit. Thirteen preterm neonates, 7 boys and 6 girls, born after 26 4/7-32 weeks' gestation with birth weights between 680 and 1800 g were studied. At the age of 21 days they all showed clinical and radiological evidence of BPD and despite maximal therapy they deteriorated during the last week before entering into the study. The potentially successful dexamethasone schedule of Avery was started. After four days' therapy only 3 patients out of 13 were still on the ventilator. Ventilatory support could be stopped in all neonates after 4.7 (SD 2.0) days. No hypertension or hyperglycaemia was seen. Only 1 child had a positive blood culture; this was successfully treated. In the end two children died. The use of corticosteroids in bronchopulmonary dysplasia in this study showed a positive short-term effect. Long-term sequelae and the risk of infection are still controversial.
Similar articles
-
[Dexamethasone therapy in bronchopulmonary dysplasia].Klin Padiatr. 1989 Jan-Feb;201(1):11-5. doi: 10.1055/s-2007-1025268. Klin Padiatr. 1989. PMID: 2495383 German.
-
Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease.Arch Dis Child Fetal Neonatal Ed. 2011 May;96(3):F190-4. doi: 10.1136/adc.2010.187203. Epub 2010 Nov 29. Arch Dis Child Fetal Neonatal Ed. 2011. PMID: 21115554
-
Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia.J Perinat Med. 2008;36(4):359-64. doi: 10.1515/JPM.2008.056. J Perinat Med. 2008. PMID: 18598128
-
Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions.Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S33-7; discussion S37-9. doi: 10.1097/01.inf.0000053883.08663.e5. Pediatr Infect Dis J. 2003. PMID: 12671450 Review.
-
Evidence-based neonatal pharmacotherapy: postnatal corticosteroids.Clin Perinatol. 2012 Mar;39(1):47-59. doi: 10.1016/j.clp.2011.12.017. Clin Perinatol. 2012. PMID: 22341536 Review.